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Background: It remains to be clarified if the application of noninvasive positive pressure ventilation (NPPV) is
effective after extubation in patients with hypoxemic respiratory failure who require the sufficient level of positive
end-expiratory pressure (PEEP). This study was aimed at examining the effect and the safety of NPPV application
following extubation in patients requiring moderate PEEP level for sufficient oxygenation after cardiovascular surgery.
Methods: With institutional ethic committee approval, the patients ventilated invasively for over 48 h after
cardiovascular surgery were enrolled in this study. The patients who failed the first spontaneous breathing trial (SBT)
at 5 cmH2O of PEEP, but passed the second SBT at 8 cmH2O of PEEP, received NPPV immediately after extubation
following our weaning protocol. Respiratory parameters (partial pressure of arterial oxygen tension to inspiratory
oxygen fraction ratio: P/F ratio, respiratory ratio, and partial pressure of arterial carbon dioxide: PaCO2) 2 h after
extubation were evaluated with those just before extubation as the primary outcome. The rate of re-intubation, the
frequency of respiratory failure and intolerance of NPPV, the duration of NPPV, and the length of intensive care unit
(ICU) stay were also recorded.
Results: While 51 postcardiovascular surgery patients were screened, 6 patients who met the criteria received
NPPV after extubation. P/F ratio was increased significantly after extubation compared with that before extubation
(325 ± 85 versus 245 ± 55 mmHg, p < 0.05). The other respiratory parameters did not change significantly.
Re-intubation, respiratory failure, and intolerance of NPPV never occurred. The duration of NPPV and the length of
ICU stay were 2.7 ± 0.7 (SD) and 7.5 (6 to 10) (interquartile range) days, respectively.
Conclusions: While further investigation should be warranted, NPPV could be applied effectively and safely after
extubation in patients requiring the moderate PEEP level after cardiovascular surgery.
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Prolonged invasive mechanical ventilation (IMV) through
endotracheal tube, appreciated as the most efficient way to
provide sufficient oxygenation in patients with respiratory
failure, is ironically likely to cause various complications
such as ventilator-induced lung injury and ventilator-
associated pneumonia, leading to an increase of mortality
[1,2]. Thus, one of the major goals in the intensive care
unit (ICU) is to wean critical ill patients from such IMV as
early as possible without consequent respiratory failure
and re-intubation. A number of clinical trials have demon-
strated that the clinical strategy such as daily interruption
of sedation [3], protocol-based sedation [4], and awaking
and breathing trial [5] to obviate the prolonged duration of
IMV is beneficial.
Previous studies showed that noninvasive positive pres-
sure ventilation (NPPV) is safe and effective to facilitate
weaning from IMV in especially medical patients requiring
long-term ventilatory support for predominantly hyper-
capnic respiratory failure [6-8]. However, there are few
data which describe the effectiveness of NPPV to facilitate
the process of liberation from IMV in patients with hypox-
emic respiratory failure. Due to severe postoperative pul-
monary complications such as atelectasis, pulmonary
edema, pneumonia, and phrenic nerve palsy, postcardio-
vascular surgery patients often develop hypoxemic respira-
tory failure requiring high level of positive end-expiratory
pressure (PEEP) for sufficient oxygenation and could suf-
fer from prolonged IMV [9,10]. Although NPPV has been
used widely for postoperative respiratory failure [11,12],
there are few studies to examine whether NPPV can be
applied effectively and safely after extubation in such
population who requires sufficient PEEP level and long-
term ventilator support after cardiovascular surgery.
We, therefore, designed the present study to evaluate
the effect and the safety of our weaning protocol in
which NPPV was applied after extubation in these pa-
tients who were mechanically ventilated for over 48 h
and simultaneously required moderate PEEP level for
sufficient oxygenation after cardiovascular surgery.
Methods
We conducted this prospective observational study in
our eight-bed ICU of Kawasaki Municipal Hospital in
Japan. Institutional review board approval was obtained
and thereby allowed us to wave the need of informed
consent since this is an observational study and the ap-
plication of NPPV after extubation is performed in a
routine manner in our ICU.
Study protocol
Patients who underwent cardiovascular surgery from April
2011 to December 2011 in our hospital were screened.
All patients who received mechanical ventilation viaendotracheal tube for over 48 h after cardiovascular sur-
gery were enrolled in this study. Exclusion criteria were
younger than 20 years old, body mass index over 35, and
chronic renal failure requiring hemodialysis. We excluded
patients on hemodialysis since extubation from moderate
PEEP level through NPPV application might be hazardous
due to the impracticality of constant diuresis in these
patients. Additionally, the patients who could not be
weaned from IMV or died within 14 postoperative days
(POD) were excluded from the study. Eligible patients
were screened every morning and considered ready for
weaning if they met all the following weaning criteria:
(1) hemodynamic stability requiring less than 3 μg/kg/min
of dopamine or dobutamine and/or less than 0.02 μg/kg/
min of norepinephrine, (2) partial pressure of arterial oxy-
gen tension to inspiratory oxygen fraction ratio (P/F ratio)
more than or equal to 200 mmHg with PEEP of 10
cmH2O or less, (3) adequate conscious level and cough re-
flex, and (4) absence of hyperthermia (>38°C) or suspected
pneumonia. Pneumonia was suspected in patients with a
new or worsened pulmonary infiltrate on chest X-ray who
meets any two of the following three criteria: leukocyte
count above 12,000 or below 4,000/μL, body temperature
above 38°C and/or the presence of purulent respiratory
secretions. Patients who met all these weaning criteria
were initiated to wean from IMV following our protocol
(Figure 1). This protocol was quite different from the
conventional one in which the trachea was extubated only
after successful spontaneous breathing trial (SBT) at 5
cmH2O of PEEP.
The first SBT was performed under continuous positive
airway pressure (CPAP) mode with pressure support (PS)
for 2 h at the following setting: PEEP equal to 5 cmH2O,
PS equal to 5 cmH2O, and inspiratory oxygen fraction
(FIO2) equal to or less than 0.5. If the patients could toler-
ate the first SBT in accordance with our extubation criteria
described below, the trachea was extubated. The extu-
bation criteria were as follows: (1) P/F ratio ≧200 mmHg,
(2) respiratory ratio <30/min, (3) rapid shallow breath-
ing index (the ratio of respiratory frequency to tidal
volume) <105, (4) variability of blood pressure and heart
rate <20%, (5) adequate conscious level and cough re-
flex, and (6) no agitation. If the first SBT failed, the sec-
ond SBT was performed for 2 h at the following setting
immediately after the first SBT followed by recruitment
maneuver (30 cmH2O for 30 s) application, CPAP mode
with PEEP equal to 8 cmH2O, PS equal to 5 cmH2O,
and FIO2 equal to or less than 0.5. If the extubation
criteria during the second SBT were confirmed, they
received sequential NPPV (BiPAP vision, Respironics,
Murrysvile, PA, USA) through a full facial mask imme-
diately after extubation. NPPV was delivered at the
CPAP mode with 8 cmH2O of PEEP and the same FIO2
as before extubation. During NPPV, all patients were
SBT at the following setting for 2 hours
CPAP: FIO2 0.5, PEEP 5cmH2O, PS 5cmH2O
Meet the extubation criteria? 
Extubation to oxygen mask SBT at the following setting for 2 hours after RM
CPAP: FIO2 0.5, PEEP 8cmH2O, PS 5cmH2O
Meet the extubation criteria? 
Extubation followed by NPPV at the following setting
CPAP: FIO2 0.5, PEEP 8cmH2O





Figure 1 Study protocol for weaning from invasive ventilator support. SBT, spontaneous breathing trial; CPAP, continuous positive airway
pressure; FIO2, inspiratory oxygen fraction; PEEP, positive end-expiratory pressure; PS, pressure support; RM, recruitment maneuver, RM was
performed at the pressure of 30 cmH2O for 30 s; SIMV, synchronized intermittent mandatory ventilation.
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0.7 μg/kg/hr) to relieve discomfort. Ventilator setting
was not changed for 2 h if O2 saturation monitored by
pulse oximetry (SpO2) was maintained more than 92%
and respiratory rate was less than 35 breaths/min. At
2 h after extubation, the setting was adjusted to achieve
SpO2 >94% and respiratory rate <30 breaths/min if
necessary. The physicians in charge were allowed to use
S/T mode with different inspiratory and expiratory posi-
tive pressure at any time if indicated. NPPV was applied
at least for 12 h and weaned by reducing positive pres-
sure level gradually by 2 cmH2O while maintaining
SpO2 >94% and respiratory rate <30 breaths/min. Since
the reason why these patients require moderate PEEP
for sufficient oxygenation should be overhydration, we
dehydrated these patients using diuretics to wean from
NPPV while paying strict attentions to hemodynamic
stability. Once the PEEP level of 4cmH2O and FIO2
equal to or less than 0.5 were achieved, arterial blood
gases were analyzed 2 h later. If P/F ratio was above
200 mmHg, patients were weaned from NPPV and re-
ceived O2 mask (total flow, 30 L/min; FIO2, 0.5). Weaning
from NPPV was considered as successful unless respira-
tory failure developed for 24 h after liberation from NPPV,
defined as the presence of any of the following criteria: (1)
severe hypoxemia with SpO2 <92% or PaO2 <70 mmHg at
FIO2 of 0.5 or more, (2) respiratory rate >35 breaths/min,
(3) respiratory acidosis (arterial pH <7.3 with a partial
pressure of arterial carbon dioxide (PaCO2) >50 mmHg),
(4) clinical signs of respiratory muscle fatigue such as useof accessory muscle and paradoxical motion of the abdo-
men, (5) inability to remove tracheal secretions, or (6)
severe dyspnea.
Criteria for re-intubation
Patients were immediately intubated if any of the follow-
ing criteria was unmasked: (1) respiratory or cardiac ar-
rest, (2) respiratory pauses with loss of consciousness or
gasping, (3) uncontrolled agitation, (4) massive aspir-
ation, (5) the inability to remove respiratory secretions,
or (6) hemodynamic instability unresolved by fluids and
vasoactive agents. Furthermore, the patients were re-
intubated if respiratory failure described above persisted
for over 4 h despite adjustment of ventilator setting and
possible medical or physical therapy.
Measurement parameters
At baseline, demographic data, SOFA score at ICU ad-
mission, diagnosis for surgery, and duration of IMV be-
fore extubation were recorded. Arterial pressure, heart
rate, respiratory rate, and SpO2 were monitored continu-
ously, whereas arterial blood gases were analyzed at 7 a.m.
every morning, just before extubation, 2 h after initiation
of NPPV and any time if indicated. The duration of NPPV,
the presence of re-intubation or respiratory failure, and
the length of ICU stay were also recorded. The primary
end-point was the changes of respiratory parameters in-
cluding P/F ratio, respiratory rate, and PaCO2, 2 h after
initiation of NPPV compared with those just before extu-
bation. The secondary end-points were the changes of
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heart rate) after initiation of NPPV, the rate of re-
intubation, the frequency of respiratory failure and intoler-
ance of NPPV, the duration of NPPV, and the length of
ICU stay.
Statistical analysis
Continuous variables were presented as means ± stand-
ard deviation (SD), or medians and interquartile ranges,
and compared by Student’s t test for variables with a
normal distribution and by Mann–Whitney U test for var-
iables with a non-normal distribution. Categorial valuables
were compared by Fisher’s exact probability test. A p value
of <0.05 was considered as statistically significant.
Results
Fifty-one patients underwent cardiovascular surgery dur-
ing the study period. Among them, 27 patients were
weaned from IMV within 48 h after surgery, whereas the
rest were screened for the eligibility of this study. One
patient was excluded from the study because of chronic
renal failure requiring hemodialysis. Of another 23 pa-
tients, 12 patients were weaned from IMV to face mask
in accordance with the weaning protocol of our institute
after the first SBT at 5 cmH2O PEEP (Figure 1), of whom
3 patients were re-intubated and 2 of them underwent
tracheostomy at 15 and 16 POD. Among other 11 pa-
tients, 5 patients did not meet the extubation criteria
(second failure). Namely, two patients had tracheostomy
at 15 and 21 POD, one patient died at 10 POD due to
acute myocardial infarction, and two patients died at 13
and 18 POD due to multiple organ failure with severe
sepsis before extubation. After all, six eligible patients
who met the extubation criteria after the second SBT
were enrolled for this trial. Clinical characteristics of
these patients are summarized in Table 1. Before the
successful second SBT, five of six patients failed the first
SBT because of hypoxemia (P/F ratio <200 mmHg) and
another one patient progressed to tachypnea (respiratory
rate ≧30 breaths/min).Table 1 Characteristics of six patients weaned from invasive m








1 55 F 161 66 MR, TR MVR, TAP 7 h
2 72 M 166 66 Atrial fibrillation Maze operation 6 h
3 79 F 148 57 Angina CABG 5 h
4 71 M 161 52 Angina CABG 6 h





6 85 M 160 58 Angina CABG 3 h
NPPV, non-invasive positive pressure ventilation; SOFA score, sequential organ failu
pressure of arterial oxygen tension to inspiratory oxygen fraction ratio; RR, respirato
MVR, mitral valve replacement; TAP, tricuspid annuloplasty; CABG, coronary artery bIn all six patients, NPPV was performed successfully
over 12 h without adjusting ventilator setting. The changes
of respiratory parameters are described in Table 2. The
P/F ratio increased significantly 2 h after initiation of
NPPV compared with just before extubation (325 ±
85 mmHg versus 245 ± 55 mmHg, p < 0.05), while re-
spiratory rate and PaCO2 did not change significantly
(17 ± 5.5/min versus 18.2 ± 6.5/min and 33.2 ± 5.3 mmHg
versus 34.0 ± 5.1 mmHg, respectively). Hemodynamic pa-
rameters including systolic blood pressure and heart rate
did not change significantly after initiation of NPPV com-
pared with those before extubation (Table 3). No patients
needed re-intubation or developed respiratory failure after
application of NPPV. All patients tolerated the whole
NPPV procedure. The duration of NPPV was 2.7 ±
0.7 days, and the length of ICU stay was 7.5 (6 to 10) days.
However, the rate of re-intubation and the length of ICU
stay of these six patients did not reach statistically signifi-
cant difference compared with those of 12 patients who
were extubated to oxygen face mask more than 48 h after
surgeries at low PEEP level of 5 cmH2O (0/6 versus 3/12;
p = 0.515, 7.5 (6 to 10) versus 5.5 (4.5 to 8.5) days;
p = 0.256). All six patients were discharged from the hos-
pital without any severe consequences.
Discussion
The present study showed that an application of NPPV
after extubation is safe and effective in patients requiring
moderate level of PEEP after cardiovascular surgery. In
particular, P/F ratio at 2 h after induction of NPPV im-
proved significantly rather than before extubation. Fur-
thermore, all patients weaned from NPPV successfully
without the need of re-intubation and the development
of respiratory failure.
NPPV has been used widely now not only in ICU but
also in general wards [13], and the efficacy of this tech-
nique has been reported in various clinical situations, such
as exacerbation of chronic obstructive pulmonary disease
(COPD) [14], cardiac pulmonary edema [15], and postop-











and 04 min 8 8 P/F ratio <200 mmHg 2
and 00 min 8 3 P/F ratio <200 mmHg 2
and 47 min 7 4 P/F ratio <200 mmHg 4
and 48 min 8 6 RR ≧30/min 2
and 47 min 11 8 P/F ratio <200 mmHg 3
and 17 min 5 3 P/F ratio <200 mmHg 3
re assessment score; IMV, invasive mechanical ventilation; P/F ratio, partial
ry ratio; M, male; F, female; MR, mitral regurgitation; TR, tricuspid regurgitation;
ypass grafting.
Table 2 The changes of respiratory parameters in six eligible patients before and after NPPV application
No. P/F ratio (mmHg) RR ( /min) PaCO2 (mmHg)
Before After Before After Before After
1 201.2 287.4 15 12 32.6 33.0
2 248.3 280.4 13 11 33.3 36.5
3 246.4 298.2 16 14 36.7 28.9
4 351.2 458.4 31 25 34.1 34.7
5 206.6 228.6 18 20 41.3 40.6
6 219.2 398 16 20 25.8 25.7
mean ± SD 245 ± 55 325 ± 85* 18.2 ± 6.5 17.0 ± 5.5 34.0 ± 5.1 33.2 ± 5.3
*p < 0.05 compared with before. P/F ratio, partial pressure of arterial oxygen tension to inspiratory oxygen fraction ratio; RR, respiratory ratio; PaCO2, partial
pressure of arterial carbon dioxide.
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ing from IMV in patients who required long-term ventila-
tor support and suffered from persistent weaning failure
[6-8], our study is quite different from these previous
studies in some points. Contrary to previous studies which
included medial ICU patients with predominantly hyper-
capnic COPD patients, our study targeted only patients
who have risk factors for developing hypoxemic respiratory
failure after cardiovascular surgery. Besides, we applied
NPPV after extubation in patients who could maintain
sufficient oxygenation at PEEP level of 8 cmH2O but failed
at 5 cmH2O PEEP following our weaning protocol in this
study. We guessed that the major reasons why these six
patients required moderate PEEP level were atelectasis,
overhydration, and cardiogenic pulmonary edema due to
the long procedure of cardiac surgery and large amount of
transfusion required for perioperative hemodynamic stabil-
ity. Thus, it is unclear whether this weaning technique can
be generalized to other type of hypoxemic respiratory
failure patients. However, one recent small randomized
controlled study, including 20 patients, demonstrated that
NPPV application after early extubation from moderate
level of PEEP was beneficial in non-surgical patients with
resolving hypoxemic respiratory failure [16]. Furthermore,
early application of nasal CPAP after extubation from 7 cmTable 3 The changes of hemodynamic parameters in six
eligible patients before and after NPPV application
No. Systolic BP (mmHg) HR (beats/min)
Before After Before After
1 122 113 89 78
2 145 135 94 87
3 112 121 79 85
4 108 102 82 78
5 138 136 61 65
6 142 128 71 62
mean ± SD 128 ± 16 123 ± 13 79 ± 12 76 ± 10
NPPV, noninvasive positive pressure ventilation; BP, blood pressure; HR, heart rate.H2O PEEP was reported to reduce pulmonary morbidity
and length of hospital stay following the surgical repair of
thoracoabdominal aortic aneurysms [17]. Thus, weaning
strategy through NPPV for patients requiring moderate
level of PEEP might be beneficial in wide range of hypox-
emic respiratory failure, which should be confirmed by a
large randomized controlled trial.
Oxygenation improved significantly after the initiation
of NPPV compared with before extubation even though
the applied PEEP level was the same (8 cmH2O). While
the exact mechanisms for this improvement is unknown,
some possible mechanisms are considered, such as ab-
sence of sedation other than dexmedetomidine, increased
patient’s activity, and improvement of dorsal ventilation
leading to reduced V/Q mismatch. Although this im-
provement of oxygenation could support the use of this
weaning strategy, there are some concerns to apply this
technique. Delayed intubation after developing respiratory
failure is associated with worse outcome [18,19], thereby
re-intubation should not be hesitated if respiratory failure
once develops. The protocol to prevent delayed re-
intubation should be made in all ICU where patients with
respiratory failure are treated by NPPV. Tolerance of pa-
tients is also one of the key factors in managing NPPV
successfully. Although patients were sedated with remifen-
tanil or propofol to increase NPPV tolerance in previous
studies [20,21], we used continuous dexmedetomidine in-
fusion, which has little respiratory depressant effects, to
relieve discomfort as a routine practice, probably contrib-
uting to the high successful rate of NPPV management in
our ICU.
There are several limitations to interpret the data herein.
First, this study is not a randomized controlled trial but an
observational study, and the sample size was too small. It
remains unknown whether this technique can reduce the
length of mechanical ventilation, the rate of complication
relating to IMV, the length of ICU stay, and the mortality
compared with the conventional weaning strategy. How-
ever, all 6 patients enrolled in this study could wean from
IMV through application of NPPV without any progression
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of 12 patients who were liberated from IMV to oxygen face
mask were re-intubated even though they passed SBT at
the low PEEP level (5 cmH2O). Although the rate of re-
intubation did not reach significant difference, this might
be attributed to the small sample size. Whether this wean-
ing strategy could reduce the rate of re-intubation, it should
be evaluated in a randomized controlled trial in the future.
Second, we performed two sequential SBT for 4 h in this
study protocol which could be too long procedure, while
some weaning guideline recommends SBT should be per-
formed every 24 h [22]. However, there are no evidences as
to the appropriate duration of SBT. Finally, there is no ra-
tionale for 8 cm H2O of PEEP level at which trachea were
extubated in this study. It may be plausible that patients
could be liberated from IMV at higher level of PEEP, which
should be examined in a future study.
Conclusions
Application of NPPV after liberation from IMV via tra-
cheal intubation was safe and effective in patients who re-
quired moderate level of PEEP for sufficient oxygenation
after cardiovascular surgery. The P/F ratio improved sig-
nificantly 2 h after initiation of NPPV compared with that
just before extubation, and all patients could wean suc-
cessfully without development of respiratory failure and
re-intubation. A randomized controlled trial is warranted
to confirm the effectiveness of this technique before it is
widely used in other ICU.
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